257 Followers on Owler

Pharmacyclics

Pharmacyclics is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and immune mediated diseases Read more

Wulff-Erik von Borcke's photo - President of Pharmacyclics

President

Wulff-Erik von Borcke

CEO Approval Rating

83/100

Founded:

1991

Status:

PrivateAcquired by Abbvie Inc.

PHARMACYCLICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Incyte is one of Pharmacyclics's top competitors. Incyte was founded in 1991 in Wilmington, Delaware. Like Pharmacyclics, Incyte also operates in the Pharmaceuticals industry. Incyte generates $1.9B more revenue than Pharmacyclics.

Medivation is a top competitor of Pharmacyclics. Medivation was founded in 2003, and is headquartered in San Francisco, California. Like Pharmacyclics, Medivation also competes in the Pharmaceuticals field. Medivation generates $214.5M more revenue vs. Pharmacyclics.

ARIAD is seen as one of Pharmacyclics's top competitors. ARIAD is headquartered in Cambridge, Massachusetts, and was founded in 1991. Like Pharmacyclics, ARIAD also operates in the Pharmaceuticals field. ARIAD generates 23% the revenue of Pharmacyclics.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 607 a good estimate for Pharmacyclics's Employee count?

Pharmacyclics Acquisitions

No recent acquisitions found related to Pharmacyclics

Pharmacyclics Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Oct 1995
--

Since Pharmacyclics was founded in 1991, it has participated in 1 round of funding. In total Pharmacyclics has raised $0. Pharmacyclics' funding round was on Oct 1995 for a total of $0

Pharmacyclics Investments

No recent investments found related to Pharmacyclics

Pharmacyclics News

November 19, 2018BioPortfolio

Pharmacyclics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13112018 Prices from USD $250

SummaryPharmacyclics Inc Pharmacyclics a whollyowned subsidiary of AbbVie discovers develops and comm... See more »
July 28, 2018BioPortfolio

Pharmacyclics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25042018 Prices from USD $250

SummaryPharmacyclics Inc Pharmacyclics a whollyowned subsidiary of AbbVie discovers develops and comm... See more »
May 29, 2018Contract Pharma

Oncternal, Pharmacyclics Enter Supply Agreement

Pharmacyclics to supply ibrutinib, a small molecule inhibitor of Bruton's tyrosine kinase (BTK), for ... See more »
May 15, 2018Business Insider

A big drugmaker is backing away from a plan to triple the price of a lifesaving cancer drug after facing a public backlash

Thomson ReutersDrugmaker Pharmacyclics had tripled the cost of a lifesaving cancer blood treatment wh... See more »
December 11, 2017FiercePharma

J&J, AbbVie tout long-term Imbruvica data in the face of a new AstraZeneca threat

Johnson & Johnson and AbbVie have racked up some new long-term Imbruvica stats showing that the blood... See more »
November 30, 2017Military Technologies News

Global Ibrutinib Market 2017 - Pharmacyclics Inc., Janssen Biotech Inc.

Deerfield Beach, FL - (SBWIRE) - 11/29/2017 - Global Ibrutinib Market 2017 Survival Strategies explor... See more »
November 3, 2017BioPortfolio

Pharmacyclics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25102017 Prices from USD $250

SummaryPharmacyclics Inc Pharmacyclics a whollyowned subsidiary of AbbVie discovers develops and comm... See more »

Pharmacyclics Press Releases

November 13, 2015PR NEWSWIRE

AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA

NORTH CHICAGO, Ill., Nov. 13, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical co... See more »
July 19, 2015PR-INSIDE.COM

Pharmacyclics, Inc. (PCYC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Pharmacyclics, Inc. (Pharmacyclics) is a fully integrated biopharmaceutical company. ... See more »
July 2, 2015PRSYNC

Pharmacyclics, Inc. - Product Pipeline Review - 2015 by Market Research Store

Pharmacyclics, Inc. - Product Pipeline Review - 2015 Summary This 'Pharmacyclics, Inc. - Product Pipe... See more »
June 4, 2015PR NEWSWIRE

Ibrutinib (IMBRUVICA®) Improved Survival for Treatment-Naive Chronic Lymphocytic Leukemia Patients in Phase III RESONATE -2 Trial

SUNNYVALE, Calif., June 4, 2015 /PRNewswire/ -- Today, Pharmacyclics LLC, an AbbVie company, announce... See more »
May 26, 2015PR NEWSWIRE

AbbVie Completes Acquisition of Pharmacyclics

NORTH CHICAGO, Ill., May 26, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical com... See more »
May 22, 2015PR NEWSWIRE

AbbVie Announces Expiration of Hart-Scott-Rodino Waiting Period for AbbVie's Acquisition of Pharmacyclics

NORTH CHICAGO, Ill., May 22, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that the waitin... See more »

Social Media

Pharmacyclics Headquarters

995 East Arques Avenue

Sunnyvale, California94085

1-408-215-3000

Driving Directions »

Trending Companies

Pharmacyclics Summary

ABOUT

Overview

Pharmacyclics is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and immune mediated diseases Pharmacyclics was founded in 1991. Pharmacyclics' headquarters is located in Sunnyvale, California, ...

CEO

Pharmacyclics's President, Wulff-Erik von Borcke, currently has an approval rating of 83%. Pharmacyclics's primary competitors are Incyte, Medivation & ARIAD.

Frequently Asked Questions about Pharmacyclics

  1. When was Pharmacyclics founded?

    Pharmacyclics was founded in 1991
  2. Who is Pharmacyclics's CEO?

    Pharmacyclics's CEO is Wulff-Erik von Borcke
  3. How much revenue does Pharmacyclics generate?

    Pharmacyclics generates $782.1M in revenue
  4. How much funding does Pharmacyclics have?

    Pharmacyclics has historically raised $0 in funding
  1. Where is Pharmacyclics's headquarters?

    Pharmacyclics's headquarters is in Sunnyvale California, USA
  2. How many employees does Pharmacyclics have?

    Pharmacyclics has 607 employees
  3. What sector does Pharmacyclics operate in?

    Pharmacyclics is in Pharmaceuticals
  4. Who are Pharmacyclics's competitors?

    Pharmacyclics's top competitors are Incyte, Medivation, ARIAD